Tuneable, Biodegradable, Lipid-Like Nanoparticles for In Vivo mRNA Delivery. Read about it in our interview with Yizhou Dong from Ohio State University.
Research
In a new study published in Nature, US-based researchers describe how they used genome-wide CRISPR screens to identify genes that allow cancer cells to evade destruction by the host cytotoxic T cell responses.
Researchers at University of Connecticut validate clinical feasibility of CRISPR-Cas12a based platform for COVID-19 testing in clinical swab samples. Results published in Nature Communications.
Conferences and Webinars
Labroots to host its 3rd Annual CRISPR Virtual Event to include discussions about current CRISPR-based editing, next-generation gene editing tools, precision, and the role of CRISPR in drug discovery and development.